128 related articles for article (PubMed ID: 15799211)
1. Spotlight on estradiol-intranasal in the management of menopause.
Dooley M; Spencer CM; Ormrod D
Treat Endocrinol; 2002; 1(3):191-4. PubMed ID: 15799211
[TBL] [Abstract][Full Text] [Related]
2. Estradiol-intranasal: a review of its use in the management of menopause.
Dooley M; Spencer CM; Ormrod D
Drugs; 2001; 61(15):2243-62. PubMed ID: 11772138
[TBL] [Abstract][Full Text] [Related]
3. Spotlight on estradiol and norgestimate as hormone replacement therapy in postmenopausal women.
Curran MP; Wagstaff AJ
Treat Endocrinol; 2002; 1(2):127-9. PubMed ID: 15765628
[TBL] [Abstract][Full Text] [Related]
4. Estradiol and norgestimate: a review of their combined use as hormone replacement therapy in postmenopausal women.
Curran MP; Wagstaff AJ
Drugs Aging; 2001; 18(11):863-85. PubMed ID: 11772126
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and acceptability of intranasal 17 beta-oestradiol for menopausal symptoms: randomised dose-response study. Aerodiol Study Group.
Studd J; Pornel B; Marton I; Bringer J; Varin C; Tsouderos Y; Christiansen C
Lancet; 1999 May; 353(9164):1574-8. PubMed ID: 10334256
[TBL] [Abstract][Full Text] [Related]
6. Pulsed estrogen therapy: relieving climacteric symptoms, preventing postmenopausal bone loss.
Palacios S
Climacteric; 2002 Jun; 5 Suppl 2():32-9. PubMed ID: 12482109
[TBL] [Abstract][Full Text] [Related]
7. Effects of intranasal 17beta-estradiol on bone turnover and serum insulin-like growth factor I in postmenopausal women.
Garnero P; Tsouderos Y; Marton I; Pelissier C; Varin C; Delmas PD
J Clin Endocrinol Metab; 1999 Jul; 84(7):2390-7. PubMed ID: 10404809
[TBL] [Abstract][Full Text] [Related]
8. [Aerodiol: the efficacy and tolerability of intranasal estrogen administration. An overview].
Genazzani AR; Cappagli B; Ciaponi M
Minerva Ginecol; 2003 Jun; 55(3):189-200. PubMed ID: 14581864
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of pulsed estrogen therapy: a 12-week double-blind placebo-controlled study in highly symptomatic postmenopausal women.
Rozenbaum H; Chevallier O; Moyal M; Durand G; Perineau M; This P;
Climacteric; 2002 Sep; 5(3):249-58. PubMed ID: 12419083
[TBL] [Abstract][Full Text] [Related]
10. Clinical equivalence of intranasal and oral 17beta-estradiol for postmenopausal symptoms.
Mattsson LA; Christiansen C; Colau JC; Palacios S; Kenemans P; Bergeron C; Chevallier O; Von Holst T; Gangar K
Am J Obstet Gynecol; 2000 Mar; 182(3):545-52. PubMed ID: 10739506
[TBL] [Abstract][Full Text] [Related]
11. Effects of low-dose norethindrone acetate plus ethinyl estradiol (0.5 mg/2.5 microg) in women with postmenopausal symptoms: updated analysis of three randomized, controlled trials.
Rowan JP; Simon JA; Speroff L; Ellman H
Clin Ther; 2006 Jun; 28(6):921-32. PubMed ID: 16860174
[TBL] [Abstract][Full Text] [Related]
12. Endometrium protection and acceptability of nasally administered continuously combined hormone therapy: a multicentre, multinational, double-blind trial in post-menopausal women evaluating three regimens of 17beta-estradiol and norethisterone when compared with an orally administered 17beta-estradiol norethisterone regimen.
Rozenberg S; Pornel B; Koninckx PR; Palacios S; Christiansen C
Hum Reprod; 2009 Jul; 24(7):1739-47. PubMed ID: 19351658
[TBL] [Abstract][Full Text] [Related]
13. A dose-ranging trial of a matrix transdermal 17beta-estradiol for the prevention of bone loss in early postmenopausal women. International Study Group.
Delmas PD; Pornel B; Felsenberg D; Garnero P; Hardy P; Pilate C; Dain MP
Bone; 1999 May; 24(5):517-23. PubMed ID: 10321913
[TBL] [Abstract][Full Text] [Related]
14. Clinical equivalence of intranasal estradiol and oral estrogens for postmenopausal symptoms.
Ozsoy M; Oral B; Ozsoy D
Int J Gynaecol Obstet; 2002 Nov; 79(2):143-6. PubMed ID: 12427399
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of a novel estradiol vaginal ring for relief of menopausal symptoms.
Speroff L
Obstet Gynecol; 2003 Oct; 102(4):823-34. PubMed ID: 14551014
[TBL] [Abstract][Full Text] [Related]
16. Estradiol valerate/dienogest.
Wellington K; Perry CM
Drugs; 2002; 62(3):491-504; discussion 505-6. PubMed ID: 11827562
[TBL] [Abstract][Full Text] [Related]
17. Randomized comparison of intranasal and transdermal estradiol.
Lopes P; Merkus HM; Nauman J; Bruschi F; Foidart JM; Calaf J
Obstet Gynecol; 2000 Dec; 96(6):906-12. PubMed ID: 11084176
[TBL] [Abstract][Full Text] [Related]
18. Estradiol and dydrogesterone. A review of their combined use as hormone replacement therapy in postmenopausal women.
Foster RH; Balfour JA
Drugs Aging; 1997 Oct; 11(4):309-32. PubMed ID: 9342560
[TBL] [Abstract][Full Text] [Related]
19. Transdermal estradiol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of menopausal complaints.
Balfour JA; Heel RC
Drugs; 1990 Oct; 40(4):561-82. PubMed ID: 2083514
[TBL] [Abstract][Full Text] [Related]
20. Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids.
Rozenberg S; Ylikorkala O; Arrenbrecht S
Int J Fertil Womens Med; 1997; 42 Suppl 2():376-87. PubMed ID: 9397385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
